glp 1 weight loss results GLP-1 and injections Weight Loss Basking Ridge glp-1 results Dynamic GLP-1® glp-1

10.1038/nature20156 Nature 61 Franco-IborraS.Plaza-ZabalaA.MontpeyoM.SebastianD.VilaM.Martinez-VicenteM

Specific figures circulating on commercial sites could not be verified in peer-reviewed literature and directly conflict with the published consensus that no human trials have been conducted treat them as unverified

Novo Nordisk files for FDA approval of CagriSema, the first once-weekly combination of GLP1 and amylin analogues for weight management

Side Effects Comparison# CagriSema Side Effects# GI adverse events occurred in 79.6% of CagriSema recipients versus 39.9% on placebo in REDEFINE 1

The headline On Thursday 21 May 2026, Eli Lilly announced that participants in TRIUMPH-1, the first Phase 3 trial of retatrutide in obesity, lost an average of 28.3% of their body weight at 80 weeks on the 12 mg dose, with 45.3% losing at least 30% of their starting weight [1]

Metabolism Each persons body is unique